HRMYNASDAQ— Harmony Biosciences Holdings Price & Analysis

Harmony Biosciences Holdings

HEALTHCARE — BIOTECHNOLOGY

$41.26

+$0.10+0.24%

Market Cap: $2.40B; Large Cap
P/E Ratio: 13.11; Fwd: 10.06
EPS (TTM): $3.14
Div. Yield: N/A

Technical Summary

RSI (14)53.54Neutral

SMA (50)$39.08Bullish

SMA (200)$34.64Bullish

MACD0.6276Bearish

Bollinger$39.66 – $43.37Mid

Stochastic34.70Neutral

Company Overview

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and markets therapies for patients with rare neurological disorders. The company is headquartered in Plymouth Meeting, Pennsylvania.

Fundamental Snapshot

Revenue: $959.90M
EBITDA: $255.99M
Gross Profit: $723.99M
Operating Margin: 34.2%
Profit Margin: 18.9%
ROE: 20.5%
Book Value: $17.19
Beta: 0.93
52-Wk High: $43.49
52-Wk Low: $25.52
Avg Volume: 343.43K
PEG Ratio: N/A

Trading Data

Open: $41.60
Previous Close: $41.16
Day Range: $40.87 – $41.60
Volume: 556.86K
Shares Outstanding: 58.24M
Analyst Target: $47.36

Related Assets

Intuitive Surgical Inc

$415.40

+2.52%

VRTX

Vertex Pharmaceuticals Inc

$525.05

-0.22%

REGN

Regeneron Pharmaceuticals Inc

$752.44

-4.52%

Get Deeper Analysis

Ask Theo anything about HRMY — earnings, valuation, technicals, or portfolio fit.

Try HeyTheo Free